The novel therapy of tirzepatide peptide represents a significant advance in the management of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide825034.blogitright.com/42355652/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment